Immunogen (IMGN)
Add to Watchlists Create an Alert
17.03
-0.17 -0.99%
NASDAQ
May 22, 4:59PM
BATS Real time
Currency in USD
Immunogen Return on Assets:
-33.68% for March 31, 2013Immunogen Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -33.68% |
| Dec. 31, 2012 | -42.43% |
| Sept. 30, 2012 | -38.12% |
| June 30, 2012 | -36.60% |
| March 31, 2012 | -34.79% |
| Dec. 31, 2011 | -34.41% |
| Sept. 30, 2011 | -38.91% |
| June 30, 2011 | -37.76% |
| March 31, 2011 | -44.54% |
| Dec. 31, 2010 | -46.88% |
| Sept. 30, 2010 | -51.77% |
| June 30, 2010 | -53.42% |
| March 31, 2010 | -58.51% |
| Dec. 31, 2009 | -48.33% |
| Sept. 30, 2009 | -41.54% |
| June 30, 2009 | -38.51% |
| March 31, 2009 | -41.73% |
| Dec. 31, 2008 | -51.34% |
| Sept. 30, 2008 | -50.15% |
| June 30, 2008 | -39.57% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
IMGN Return on Assets Benchmarks
| Companies | |
|---|---|
| Merrimack Pharmaceuticals | -81.40% |
| Threshold Pharmaceuticals | 37.78% |
| Seattle Genetics | -12.54% |
IMGN Return on Assets Rankings
| Overall |
44th percentile 4464 of 8005 |
| Sector |
45th percentile 376 of 686 in Healthcare |
| Industry |
65th percentile 86 of 248 in Biotechnology |
IMGN Return on Assets Range, Past 5 Years
| Minimum | -58.51% | Mar 2010 |
| Maximum | -33.68% | Mar 2013 |
| Average | -43.15% |
